clindamycin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostoni, C; Bettocchi, S; Bono, P; Bosis, S; Gatti, E; Ippolito, G; La Vecchia, A; Marchisio, P; Pinzani, R; Taccani, V; Tagliabue, C | 1 |
| Duployez, C; Le Guern, R; Lejeune, AL; Loïez, C; Robriquet, L; Six, S; Tinez, C; Wallet, F | 1 |
2 other study(ies) available for clindamycin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Epidemiology and antimicrobial susceptibility of Staphylococcus aureus in children in a tertiary care pediatric hospital in Milan, Italy, 2017-2021.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; COVID-19; Female; Hospitals, Pediatric; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pandemics; Staphylococcal Infections; Staphylococcus aureus; Tertiary Healthcare | 2022 |
Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.
Topics: Adult; Anti-Bacterial Agents; Bacterial Toxins; Betacoronavirus; Cefotaxime; Clindamycin; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Exotoxins; Fatal Outcome; Humans; Leukocidins; Linezolid; Male; Metronidazole; Necrosis; Pandemics; Pneumonia, Staphylococcal; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Spiramycin; Staphylococcus aureus; Tomography, X-Ray Computed | 2020 |